BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8274729)

  • 1. Acute promyelocytic leukemia: from genetics to treatment.
    Grignani F; Fagioli M; Alcalay M; Longo L; Pandolfi PP; Donti E; Biondi A; Lo Coco F; Grignani F; Pelicci PG
    Blood; 1994 Jan; 83(1):10-25. PubMed ID: 8274729
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of retinoic acid in the treatment of acute promyelocytic leukemia].
    Gutiérrez de Guzmán J; Kantarjian H
    Sangre (Barc); 1993 Oct; 38(5):375-8. PubMed ID: 8140499
    [No Abstract]   [Full Text] [Related]  

  • 3. Differentiation therapy of acute promyelocytic leukemia: clinical and molecular features.
    Miller WH
    Cancer Invest; 1996; 14(2):142-50. PubMed ID: 8597899
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular pathology of acute promyelocytic leukemia.
    Chang KS
    Hematol Pathol; 1993; 7(4):209-23. PubMed ID: 8113150
    [No Abstract]   [Full Text] [Related]  

  • 5. Retinoic acid and arsenic: towards oncogene-targeted treatments of acute promyelocytic leukaemia.
    Quignon F; Chen Z; de Thé H
    Biochim Biophys Acta; 1997 Dec; 1333(3):M53-61. PubMed ID: 9426202
    [No Abstract]   [Full Text] [Related]  

  • 6. Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia.
    Chen Z; Tong JH; Dong S; Zhu J; Wang ZY; Chen SJ
    Genes Chromosomes Cancer; 1996 Mar; 15(3):147-56. PubMed ID: 8721678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [All-trans retinoic acid therapy in acute promyelocytic leukemia--current status and prospect].
    Kitamura K; Takeshita A; Ono R; Naoe T
    Rinsho Ketsueki; 1996 Sep; 37(9):760-5. PubMed ID: 8914458
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathogenetic role of the PML1RAR alpha fusion protein in acute promyelocytic leukemia.
    Grignani F; Pelicci PG
    Curr Top Microbiol Immunol; 1996; 211():269-78. PubMed ID: 8585958
    [No Abstract]   [Full Text] [Related]  

  • 9. [Arsenic and retinoic acid, toward targeted treatments of acute promyelocytic anemia?].
    de Thé H
    C R Seances Soc Biol Fil; 1998; 192(2):273-81. PubMed ID: 9759370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells.
    Rousselot P; Hardas B; Patel A; Guidez F; Gäken J; Castaigne S; Dejean A; de Thé H; Degos L; Farzaneh F
    Oncogene; 1994 Feb; 9(2):545-51. PubMed ID: 8290265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular biology of acute promyelocytic leukemia.
    Slack JL; Gallagher RE
    Cancer Treat Res; 1999; 99():75-124. PubMed ID: 9891864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of APL and the molecular basis of retinoic acid treatment.
    Casini T; Grignani F; Pelicci PG
    Int J Cancer; 1997 Feb; 70(4):473-4. PubMed ID: 9033658
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute promyelocytic leukemia. From morphology to molecular lesions.
    Mattson JC
    Clin Lab Med; 2000 Mar; 20(1):83-103, ix. PubMed ID: 10702898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular genetics of acute promyelocytic leukemia.
    Grignani F; Fagioli M; Ferrucci PF; Alcalay M; Pelicci PG
    Blood Rev; 1993 Jun; 7(2):87-93. PubMed ID: 8396481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetics of the t(15;17) translocation in acute promyelocytic leukemia.
    Biondi A; Rambaldi A; Pandolfi PP; Alcalay M; Longo L; Rossi V; Giudici G; Lo Coco F; Pelicci PG
    Recent Results Cancer Res; 1993; 131():345-59. PubMed ID: 8210653
    [No Abstract]   [Full Text] [Related]  

  • 16. Retinoic acid induces the degradation of the leukemogenic protein encoded by the promyelocytic leukemia gene fused to the retinoic acid receptor alpha gene.
    Wolf G; Smas CM
    Nutr Rev; 2000 Jul; 58(7):211-4. PubMed ID: 10941258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.
    Grimwade D; Solomon E
    Curr Top Microbiol Immunol; 1997; 220():81-112. PubMed ID: 9103677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the acute promyelocytic leukemia PML/RAR alpha protein on differentiation and survival of myeloid precursors.
    Fagioli M; Grignani F; Ferrucci PF; Alcalay M; Mencarelli A; Nicoletti I; Grignani F; Pelicci PG
    Leukemia; 1994 Apr; 8 Suppl 1():S7-11. PubMed ID: 8152308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute promyelocytic leukemia: from clinic to molecular biology.
    Chen SJ; Wang ZY; Chen Z
    Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular basis of arsenic action in promyelocytic leukemia cells].
    Wysocki R; Wiśniewska E
    Postepy Biochem; 2002; 48(2):121-30. PubMed ID: 12362602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.